Skip to main content

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Alcoa

(AA) - Get Alcoa Corporation Report

downgraded at Jefferies to Hold from Buy, Jefferies said. LME aluminum inventories are near record highs.

Abbott Laboratories

(ABT) - Get Abbott Laboratories Report

downgraded at Leerink to Market Perform, Leerink Swann said. Stock is up 30% since last October and appears fairly valued ahead of the upcoming business split.

Access Midstream Partners

(ACMP)

upgraded at Citigroup to Buy from Neutral, Citigroup said. $35 price target. Improved drop down visibility and counterparty risk profile.

A.H. Belo Corporation

(AHC) - Get A.H. Belo Corporation Class A Report

upgraded to hold at TheStreet Ratings.

TheStreet Recommends

Albemarle Corporation

(ALB) - Get Albemarle Corporation Report

rated new Equal-weight at Morgan Stanley. More upside potential in other chemical "Big Ideas."

Arrow Electronics

(ARW) - Get Arrow Electronics, Inc. Report

downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. $41 price target. Estimates also cut, given lower expected near-term demand.

BCSB Bankcorp

(BCSB)

downgraded to hold at TheStreet Ratings.

Bloomin Brands

(BLMN) - Get Bloomin' Brands, Inc. Report

rated new Neutral at Deutsche. $16 price target. Company will struggle to receive a higher multiple.

BMC Software

(BMC)

upgraded at Think Equity to Buy from Hold, Think said. $50 price target. ESM business has bottomed.

Broadcom

undefined

upgraded at RBC from Sector Perform to Outperform, RBC Capital said. $46 price target. Company has a solid product pipeline.

Boston Scientific

(BSX) - Get Boston Scientific Corporation Report

downgraded at Leerink to Market Perform, Leerink Swann said. $6 price target. Company will struggle to grow in declining markets.

Dover Corp

(DOV) - Get Dover Corporation Report

rated new Neutral at Citigroup. $64 price target. Still in transition with plenty of energy.

Fairchild Semiconductor

undefined

downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. $16 price target. Company is leveraged to slower macro growth.

Intel

(INTC) - Get Intel Corporation Report

downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $24 price target. PC market faces near-term headwinds.

Lamar Advertising

(LAMR) - Get Lamar Advertising Company Class A Report

upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company also placed on the Conviction List. $42 price target. Expect value from a likely REIT conversion.

Manhattan Associates

(MANH) - Get Manhattan Associates, Inc. Report

upgraded at Think to Buy from Hold, ThinkEquity said. $67 price target. Steady IT spending trends.

Molina Healthcare

(MOH) - Get Molina Healthcare, Inc. Report

downgraded at Jefferies to Underperform from Hold, Jefferies said. $19 price target. Poor execution.

Marathon Petroleum

(MPC) - Get Marathon Petroleum Corporation Report

downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $65 price target.

Nvidia

(NVDA) - Get NVIDIA Corporation Report

downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $15 price target. Slower PC growth could weigh on the next few quarters.

Pall Corporation

(PLL) - Get Piedmont Lithium Inc Report

upgraded at BofA Merrill to Neutral from Underperform, Bank of America Merrill Lynch said. $65 price target. Shares appear fairly valued.

Panera Bread

(PNRA)

downgraded at Miller Tabak to Hold from Buy, Miller Tabak said. $172 price target. Valuation call.

Perrigo

(PRGO) - Get Perrigo Co. Plc Report

rated new Buy at Guggenheim. $130 price target. FDA could approve for drug classes for over-the-counter status.

Phillips 66

(PSX) - Get Phillips 66 Report

downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $53 price target. Higher industry capacity could hurt margins.

Schnitzer Steel

(SCHN) - Get Schnitzer Steel Industries, Inc. Class A Report

downgraded at Jefferies. Shares of SCHN now seen reaching $31, Jefferies said. $31 price target. Steel prices poised for a material pull back.

Silicon Laboratories

(SLAB) - Get Silicon Laboratories Inc. Report

downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. Valuation call, based on a $41 price target.

Texas Instruments

(TXN) - Get Texas Instruments Incorporated Report

downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $28 price target. Company is seeing lower end-market demand.

Watson Pharmaceuticals

(WPI)

rated new Buy at Guggenheim. $100 price target. Large generics should benefit from new legislation.

STOCK COMMENTS / EPS CHANGES

Apple

(AAPL) - Get Apple Inc. Report

estimates, target raised at Sterne Agee. Shares of AAPL now seen reaching $840, according to Sterne Agee. Estimates also increased, given higher realized iPhone sales. Buy rating.

Apple estimates, target increased at BofA/Merrill.AAPL estimates were raised through 2014, Bank of America/Merrill Lynch said. Expect higher demand for the iPhone 5. Buy rating and new $850 price target.

Amazon.com

(AMZN) - Get Amazon.com, Inc. Report

estimates upped at Topeka through 2013, Topeka Capital Markets said. Kindle Fire HD can drive near-term growth. Buy rating and $400 price target.

Actuant

(ATU)

numbers raised at UBS. Shares of ATU now seen reaching $34, UBS said. Estimates also increased post management visit. Buy rating.

Boeing

(BA) - Get Boeing Company Report

estimates, target reduced at Credit Suisse. Shares of BA now seen reaching $87.50, according to Credit Suisse. Estimates also cut, given pension headwinds. Outperform rating.

Bed Bath & Beyond

(BBBY) - Get Bed Bath & Beyond Inc. Report

numbers raised at UBS. Shares of BBBY now seen reaching $72.60, UBS said. Estimates also increased as shares reflect more optimism since Q1 results. Neutral rating.

Eaton

(ETN) - Get Eaton Corp. Plc Report

target raised at Oppenheimer to $58, Oppenheimer said. Multiple accretion looks solid. Outperform rating.

Health Net

(HNT)

numbers raised at BMO Capital. Shares of HNT now seen reaching $17, BMO said. Estimates also raised on surge of dual enrollment. Underperform rating.

Huntsman

(HUN) - Get Huntsman Corporation Report

numbers raised at Jefferies. Shares of HUN now seen reaching $16, Jefferies said. Estimates also raised on cost- cutting tailwinds. Hold rating.

Questcor Pharmaceuticals

(QCOR)

numbers raised at Oppenheimer. Shares of QCOR now seen reaching $69, Oppenheimer said. Estimates also raised following positive commentary. Outperform rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>5 Bank Stocks Bernanke Can't Hurt Anymore

>>Apple to Crush Pandora After Occupying Wall Street

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.